A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/31/2006	US7128900 Light-protection agents
10/31/2006	US7128067 Method and apparatus for generating an aerosol
10/31/2006	CA2457854C Processes for the production of alpha-difluoromethyl ornithine (dfmo)
10/31/2006	CA2427289C Fat composition and hexacosanoic acid depressant for oral or enteral administration
10/31/2006	CA2412554C 3-substituted morphines
10/31/2006	CA2406685C Oxadiazole derivatives having anticancer effects
10/31/2006	CA2383599C Methods, kits and compositions for using pyrrole derivatives
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2350560C Novel type condensed pyridazinone compounds
10/31/2006	CA2349663C Quinolinone derivative formulation and its production method
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/31/2006	CA2283457C Polyvalent carbohydrate molecules
10/31/2006	CA2281474C Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof
10/31/2006	CA2276455C Phthalazinones
10/31/2006	CA2276310C Process for the production of tetrazolylbenzopyrans
10/31/2006	CA2267160C Antimycotic gel for the treatment and prevention of skin mycoses
10/31/2006	CA2265712C Intermediates and process for preparing olanzapine
10/31/2006	CA2265686C A crystalline substance of cefditoren pivoxyl and the production of the same
10/31/2006	CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006	CA2262796C 4-substituted beta-carbolines as immunomodulators
10/31/2006	CA2250047C Monoclonal antibodies binding human growth hormone (hgh)
10/31/2006	CA2247419C Oxazole derivatives, their production and use
10/31/2006	CA2246126C New piperazine compounds
10/31/2006	CA2236925C Microencapsulated dna for vaccination and gene therapy
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/31/2006	CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/31/2006	CA2209303C Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
10/31/2006	CA2193096C Guanylic acid derivatives and their use as drugs
10/31/2006	CA2188599C Taxane class derivative based pharmaceutical compositions
10/31/2006	CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/31/2006	CA2174731C Rapamycin derivatives useful as immunosuppressants
10/31/2006	CA2157376C Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
10/31/2006	CA2142811C Novel glucan preparation
10/28/2006	CA2505569A1 Attenuation of disorders by aminoglycosides
10/27/2006	CA2505470A1 Drug delivery device
10/26/2006	WO2006113937A2 Method for treating apathy syndrome
10/26/2006	WO2006113919A2 Aryl alkyl acid derivatives for and use thereof
10/26/2006	WO2006113910A2 Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
10/26/2006	WO2006113897A2 Products and methods for in vivo secretion of monatin
10/26/2006	WO2006113889A2 Compositions and methods for modulating interleukin-10
10/26/2006	WO2006113875A2 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
10/26/2006	WO2006113853A2 Topiramate compositions for treatment of headache
10/26/2006	WO2006113842A2 Method and composition for inhibiting cell proliferation and angiogenesis
10/26/2006	WO2006113837A2 Inhibitors of akt activity
10/26/2006	WO2006113835A2 Method of stimulating immune response in certain individuals
10/26/2006	WO2006113796A2 Microbial cellulose materials for use in transdermal drug delivery system
10/26/2006	WO2006113769A1 Vanilloid receptor ligands and their use in treatments
10/26/2006	WO2006113718A2 Compositions for the treatment of neoplasms
10/26/2006	WO2006113704A2 Subtituted heteroaryl cb1 antagonists
10/26/2006	WO2006113703A2 Carboline derivatives useful in the treatment of cancer
10/26/2006	WO2006113695A1 Combination cancer therapy with bis(thiohydrazide) amide compounds
10/26/2006	WO2006113682A1 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
10/26/2006	WO2006113681A2 Plant-derived elastin binding protein ligands and methods of using the same
10/26/2006	WO2006113666A2 Amphiphilic polymers and methods of use thereof
10/26/2006	WO2006113650A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs
10/26/2006	WO2006113636A2 Preparation of sevoflurane with negligible water content
10/26/2006	WO2006113627A2 Treatment and inhibition of disease conditions using flexible heteroarotionids
10/26/2006	WO2006113623A2 Elimination of heterogeneous or mixed cell population in tumors
10/26/2006	WO2006113615A2 Anti-microbial agents and uses thereof
10/26/2006	WO2006113606A2 Histone deacetylase inhibitors
10/26/2006	WO2006113572A1 Methods of increasing natural killer cell activity for therapy
10/26/2006	WO2006113571A2 Substituted cyclopentanones for treating inflammatory bowel disease
10/26/2006	WO2006113568A2 Controlled delivery dosage form of tramadol and gabapentin
10/26/2006	WO2006113540A2 Use of ntrosylated hemoglobin
10/26/2006	WO2006113536A2 Use of pt523 for treating cancers
10/26/2006	WO2006113531A2 Combination formulation
10/26/2006	WO2006113505A2 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
10/26/2006	WO2006113495A2 Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof
10/26/2006	WO2006113483A2 Methods and compositions for treating or preventing cancer
10/26/2006	WO2006113479A2 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
10/26/2006	WO2006113471A2 N-alkyl-azacycloalkyl nmda/nr2b antagonists
10/26/2006	WO2006113468A2 Compositions of novel opioid compounds and method of use thereof
10/26/2006	WO2006113462A2 Formulations of quaternary ammonium neuromuscular blocking agents
10/26/2006	WO2006113458A1 Heterocyclic inhibitors of protein arginine methyl transferases
10/26/2006	WO2006113448A1 Pharmacological treatment for sleep apnea
10/26/2006	WO2006113432A2 Compounds, compositions and methods
10/26/2006	WO2006113426A2 Cancer treatment by combined inhibition of telomerase and tubulin activities
10/26/2006	WO2006113376A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators
10/26/2006	WO2006113368A1 Compositions and uses of amooranin compounds
10/26/2006	WO2006113308A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody
10/26/2006	WO2006113304A2 Combinations, methods and compositions for treating cancer
10/26/2006	WO2006113274A1 Biodegradable polyphosphazenes containing pyrrolidone side groups
10/26/2006	WO2006113261A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
10/26/2006	WO2006113247A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci
10/26/2006	WO2006113236A2 Novel chemical inhibitors of neutrophil activation through the sac-dependent pathway
10/26/2006	WO2006113151A2 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients
10/26/2006	WO2006113150A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/26/2006	WO2006113097A2 Methods of facilitating cell survival using neurotrophin mimetics
10/26/2006	WO2006113034A1 Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
10/26/2006	WO2006112973A2 Treatment of schizophrenia using phosphodiesterase 5 inhibitors
10/26/2006	WO2006112938A1 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
10/26/2006	WO2006112934A1 Photodynamic therapy utilizing multiple duty cycle light modulation
10/26/2006	WO2006112889A1 Dosage forms of risedronate
10/26/2006	WO2006112828A1 Azaindole derivatives as inhibitors of p38 kinase
10/26/2006	WO2006112778A1 New muscarinic receptor antagonists
10/26/2006	WO2006112772A1 Combination product
10/26/2006	WO2006112744A2 Drug composition with analgesic, anti-inflammatory and decongestive activity
10/26/2006	WO2006112705A2 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure.
10/26/2006	WO2006112694A2 Nutritional supplement with colostrum and epa or dha or gla

1 ... 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 4051 ... 7860